Cargando…
Therapiealternativen bei amyopathischer MDA5-positiver Dermatomyositis
We report a case of an atypical course of therapy in amyopathic MDA5-antibody-positive dermatomyositis with interstitial lung disease. Due to the poor prognosis, early therapy with cyclophosphamide followed by rituximab was carried out initially in addition to the administration of prednisolone. Due...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366251/ https://www.ncbi.nlm.nih.gov/pubmed/37249583 http://dx.doi.org/10.1007/s00108-023-01517-x |